Curigliano Giuseppe, European Institute of Oncology, IRCCS Milan, Italy
Giuseppe Curigliano, MD PhD, is Full Professor of Medical Oncology at the University of Milano and of the Clinical Division of Early Drug Development at European Institute of Oncology, Milano, Italy.
Dr. Curigliano is an expert in the field of advanced drug development in solid tumors, with specific interest on breast cancer. Its clinical activity is based on the genetic characterization of tumors and on testing new experimental drugs specific for particular groups of patients. Since 2001 he is tenure-track and full-time cancer specialist at European Institute of Oncology – one of the world’s leading cancer-research institutes and the premier Cancer Center in Italy and third in Europe. He serves as member of the Italian Higher Council Health. Dr. Curigliano serves ESMO as Chair of the Clinical Practice Guidelines Committee.
